A-share midday report | The three major indices are slightly lower, with the concept of CRO strength, Contemporary Amperex Technology AH shares collectively falling.
In the morning, the A-share market experienced a slight decline in the three major indexes due to volatile adjustments.
On April 28, the A-share market experienced a morning adjustment with all three major indices slightly decreasing. By midday, the Shanghai Composite Index fell by 0.07%, the Shenzhen Component Index fell by 0.41%, and the Growth Enterprise Market fell by 0.54%. The total trading volume in the Shanghai and Shenzhen markets was 1.66 trillion yuan for the morning session, a decrease of 39.6 billion yuan from the previous trading day.
In terms of specific stocks, pharmaceutical and medical stocks saw a collective increase, with artemisinin, CRO, and influenza-related stocks leading the way. Stocks like WuXi AppTec, Zhuhai Rundu Pharmaceutical, and Hunan Hansen Pharmaceutical hit the limit up. The securities sector saw a rebound, with GF SEC rising by 6.93%. Dye and chemical stocks also saw a rise, with Poly Plastic Masterbatch, MEIBANG TECHNOLOGY, and Guizhou Chitianhua increasing by over 10%. The computing power chip concept remained active, with CPU leading the way, and storage chip concepts also fluctuated. Copper foil and PCB concepts were active, with stocks like Anhui Tongguan Copper Foil Group and Xi'an Taijin New Energy & Materials Sci-Tech increasing by over 10%.
On the downside, precious metals, minor metals, and industrial metals all saw a collective decline. Shandong Nanshan Aluminium fell by over 7%. The tourism and hotel sector saw a decline, with Shaanxi Tourism Culture Industry Holding nearing the limit down. The military industry sector also saw a decline, with Chengdu M&S Electronics Technology falling by over 10%. The film and media stocks also weakened, with Hunan TV & Broadcast Intermediary hitting the limit down.
In terms of focus stocks, Contemporary Amperex Technology A-shares fell by 1.4%, while Hong Kong shares fell by over 7%. The company entered into a placement agreement with placement agents at a price of 628.20 Hong Kong dollars per share.
Additionally, two listed companies, Zhejiang Zhongjian Technology and Dalian Bio-Chem, hit the limit down at the opening. These two companies were previously announced to have been investigated by the China Securities Regulatory Commission.
In other news, "AI Optics first stock" Shanghai Xizhi Technology debuted on the Hong Kong Stock Exchange. By 11:38, Xizhi Technology-P increased by 345.1%. According to the prospectus, approximately 70% of the funds raised by Xizhi Technology will be used for research and development in the next five years, with a focus on developing high-end silicon optical chip design and high-speed optoelectronic transmission technology.
Looking ahead, Orient suggests that the ChiNext Index is consolidating after reaching a new high, while the Shanghai Composite Index is still in a rebound phase. There is still some room from the previous high points, but caution is advised, with technology still being a key sector.
Popular sectors include the CRO concept, which saw a strong performance in the pharmaceutical and medical sector. The securities sector also saw a strong performance, with GF SEC leading the way. The computing power leasing concept was active, with stocks like Guangdong Qunxing Toys Joint-stock, Three's, Jiangsu Lettall Electronic, Ningbo Construction, and Infore Environment Technology Group hitting the limit up. The computing power chip concept saw repeated activity, with Jiangsu Zongyi hitting three limits in four days and Rendong Holdings Group hitting the limit up.
Institutional views suggest a continued high demand for AI computing power, with the semiconductor industry expected to continue its high growth trend.
Related Articles

J&T EXPRESS-W (01519) spent 23.4103 million Hong Kong dollars to repurchase 2.284 million shares on April 28th.

UNITED LAB (03933): TUL321 Capsules receive approval for new drug clinical trials by the US FDA.

LEGENDHOLDING (03396) will distribute a final dividend of 0.1 yuan per share on August 28th.
J&T EXPRESS-W (01519) spent 23.4103 million Hong Kong dollars to repurchase 2.284 million shares on April 28th.

UNITED LAB (03933): TUL321 Capsules receive approval for new drug clinical trials by the US FDA.

LEGENDHOLDING (03396) will distribute a final dividend of 0.1 yuan per share on August 28th.






